确定针对Exportin-1的新型抑制剂,用于潜在的COVID-19治疗

Tanuj Sharma1, Tanmoy Mondal2,3, Sajid Khan4

  • 1Department of Family Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Gangnam-gu, Seoul, 06273, Republic of Korea.

Archives of microbiology
|January 19, 2024
PubMed
概括

研究人员使用计算方法确定了核出口蛋白1 (XPO1) 的新型抑制剂. 这些化合物在实验室测试中显示出降低SARS-CoV-2感染的潜力,这表明了潜在的新型抗病毒疗法.